CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind and Placebo-Controlled Phase I Study to Evaluate the Safety and Primary Immunogenicity of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 9-45 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03676101
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:26.735705+00:00
Published At: 2020-01-22T00:00:00+00:00
Record Updated At: 2020-01-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cervical Cancers", "Vulvar Cancer", "Vaginal Cancer", "CIN1", "CIN2", "CIN 3", "AIS", "Invasive Carcinoma", "Mild Dysplasia of Vulva", "Moderate Dysplasia of Vulva", "Vin III", "VaIN1", "VaIN2", "VaIN3", "Genital Wart"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-01-22"
protocolSection.identificationModule.nctId: "NCT03676101"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-Blind and Placebo-Controlled Phase I Study to Evaluate the Safety and Primary Immunogenicity of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 9-45 Years"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.